FY2025 · period end Jul '25 · from the 10-K filed Sep 26, 2025
| Metric | FY25Jul '25 | FY24Jul '24 | FY23Jul '23 | FY22Jul '22 | FY21Jul '21 |
|---|---|---|---|---|---|
| Revenue | $4.65B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-298722 | Jul 2, 2026 | Jul 8, 2026 | Jul 8, 2026 21:22 UTC | EDGAR |
| 8-K | 0001193125-26-286982 | Jun 23, 2026 | Jun 29, 2026 | Jun 29, 2026 13:15 UTC | EDGAR |
| 10-Q | 0001193125-26-245578 | Apr 30, 2026 | May 29, 2026 | May 28, 2026 21:34 UTC | EDGAR |
| 8-K | 0001193125-26-234447 | May 21, 2026 | May 21, 2026 | May 21, 2026 20:16 UTC | EDGAR |
| 10-Q | 0001193125-26-088593 | Jan 31, 2026 | Mar 3, 2026 | Mar 3, 2026 21:58 UTC | EDGAR |
| 8-K | 0001193125-26-059440 | Feb 19, 2026 | Feb 19, 2026 | Feb 19, 2026 21:16 UTC | EDGAR |
| 8-K | 0001193125-26-022730 | Jan 23, 2026 | Jan 26, 2026 | Jan 26, 2026 21:48 UTC | EDGAR |
| 8-K | 0001193125-25-315830 | Dec 5, 2025 | Dec 11, 2025 | Dec 11, 2025 20:42 UTC | EDGAR |
Direct links to SEC EDGAR. CPRT has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Income (Loss) Attributable to Parent·Q3 2016
Minor restatementwas$74M
Revised up in a 10-K. Any P/E built on the original was 0.8% too high.
Income Tax Expense (Benefit)·Q3 2016
Minor restatementwas$42.6M
Revised down in a 10-Q.
Income Tax Expense (Benefit)·Q1 2015
Minor restatementwas$29.3M
Revised down in a 10-Q.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent·Q3 2016
Minor restatementwas$93.3M
Revised up in a 10-Q.
Liabilities, Current·As of Jul 31, 2012
Minor restatementwas$187.4M
Revised down in a 10-K.
Increase (Decrease) in Prepaid Expense and Other Assets·Q3 2019
Major restatementwas$1.4M
Revised up in a 10-Q.
CPRT is not the only one.
See every restatement we've found across the market — or get an alert the next time CPRT revises a number.
Restatements are detected by comparing every vintage of a fact across all of COPART INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CPRT's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling COPART INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CPRT yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CPRT and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $3.87B |
| $3.50B |
| $2.69B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | $1.70B | $1.57B | $1.49B | $1.37B | $1.14B |
|---|
| Net Income | $1.55B | $1.36B | $1.24B | $1.09B | $0.94B |
|---|
| EPS (Diluted) | $1.59 | $1.40 | $1.28 | $1.13 | $0.97 |
|---|
| Metric | FY25Jul '25 | FY24Jul '24 | FY23Jul '23 | FY22Jul '22 | FY21Jul '21 |
|---|---|---|---|---|---|
| Total Assets | $10.09B | $8.43B | $6.74B | $5.31B | $4.56B |
| Total Liabilities | $0.88B | $0.88B | $0.75B | $0.68B | $1.03B |
| Stockholders' Equity | $9.19B | $7.52B | $5.99B | $4.63B | $3.53B |
| Cash & Equivalents | $2.78B | $1.51B | $0.96B | $1.38B | $1.05B |
| Total Debt | — | $0.00B | $0.01B | $0.00B | $0.40B |
| Metric | FY25Jul '25 | FY24Jul '24 | FY23Jul '23 | FY22Jul '22 | FY21Jul '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.80B | $1.47B | $1.36B | $1.18B | $0.99B |
| Capital Expenditures | $0.57B | $0.51B | $0.52B | $0.34B | $0.46B |
| Free Cash Flow | $1.23B | $0.96B | $0.85B | $0.84B | $0.53B |
| Metric | FY25Jul '25 | FY24Jul '24 | FY23Jul '23 | FY22Jul '22 | FY21Jul '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Net Margin | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| Return on Equity | 18.6% | 20.2% | 23.3% | 26.7% | 31.1% |
| Return on Assets | 16.8% | 18.0% | 20.5% | 22.1% | 23.4% |
| Debt / Equity | — | 0.00× | 0.00× | 0.00× | 0.11× |
